| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c24188a21e57c1a274e1b9e2a2d2984d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-627
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2022-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08fb6a0048095b9a053942e0060e6578
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a8471ad766065db76acf208a2426322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4958147cf66ed6f8a204a980269c2cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c563ad35e46c34a5318b0719a107609
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2160fd3551481aa730bea46db0a54dad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44d18682174a6780a9aef98f033b5714 |
| publicationDate |
2022-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022258794-A2 |
| titleOfInvention |
A conjugate |
| abstract |
A conjugate comprising at least one polypeptide comprising a sequence of a B-cell epitope and at least one polypeptide comprising a sequence of a CD4+ T-cell epitope is provided. The CD4+ T-cell epitope comprises a region of at least 12 amino acids of a universal tumour antigen or a sequence having at least 80% sequence identity to the region and the CD4+ T-cell epitope is immunogenic in at least 50% of the population. The at least one polypeptide comprising the sequence of the CD4+ T-cell epitope is equal to or less than 500 amino acids in length. The sequence of the B-cell epitope is different from the sequence of the CD4+ T-cell epitope and an antibody specific for the B-cell epitope binds to the conjugate. |
| priorityDate |
2021-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |